Research done at the Washington University School of Medicine in St. Louis raises the possibility that some cancer patients with aggressive tumors may benefit from a class of anti-inflammatory drugs used to treat rheumatoid arthritis. The investigators published their findings in a 2014 issue of the journal Cell Reports.